Position in KRYS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$4,460
-$86,985 QoQ
Shares Held
12
-96.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#382
of 419 holders
Holding Since
Sep 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Derivatives in KRYS
reported options exposure · as of Jun 30, 2026CallValue
$1,561,014
CallShares
4,200
PutValue
$371,670
PutShares
1,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names. KRYS ranks #118 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
126,005 | $33,608,053 | |
| 2 | CYTK |
Cytokinetics Inc
|
239,728 | $20,422,428 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
288,233 | $16,492,692 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
386,183 | $14,393,040 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,596 | $14,089,509 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
334,854 | $11,180,775 | |
| 7 | TYRA |
Tyra Biosciences, Inc.
|
347,898 | $11,111,862 | |
| 8 | BCAX |
Bicara Therapeutics Inc.
|
353,226 | $10,487,279 |
All Filings in KRYS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,460 | 12 | Shares | Sole | 2026-08-03 | |
| 2026-06-30 | $1,561,014 | 4,200 | Call | Sole | 2026-08-03 | |
| 2026-06-30 | $371,670 | 1,000 | Put | Sole | 2026-08-03 | |
| 2026-03-31 | $232,488 | 900 | Put | Sole | 2026-05-13 | |
| 2026-03-31 | $91,445 | 354 | Shares | Sole | 2026-05-13 | |
| 2026-03-31 | $154,992 | 600 | Call | Sole | 2026-05-13 | |
| 2024-12-31 | $266,322 | 1,700 | Put | Sole | 2025-02-13 | |
| 2024-12-31 | $626,640 | 4,000 | Call | Sole | 2025-02-13 | |
| 2024-09-30 | $382,263 | 2,100 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $200,233 | 1,100 | Put | Sole | 2024-11-14 | |
| 2024-09-30 | $17,656 | 97 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $257,096 | 1,400 | Call | Sole | 2024-08-14 | |
| 2024-06-30 | $606,012 | 3,300 | Put | Sole | 2024-08-14 | |
| 2023-06-30 | $457,860 | 3,900 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $246,540 | 2,100 | Put | Sole | 2023-08-14 | |
| 2023-03-31 | $552,414 | 6,900 | Put | Sole | 2023-05-15 | |
| 2023-03-31 | $264,198 | 3,300 | Call | Sole | 2023-05-15 | |
| 2022-09-30 | $48,790 | 700 | Call | Sole | 2022-11-14 | |
| 2022-09-30 | $209,100 | 3,000 | Put | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||